Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Bronchiectasis poses deadly risk for COPD patients

  • 1 Comment

New research warns health professionals that patients with COPD are more likely to die from bronchiectasis.

The condition which sees the airways in the lungs become permanently dilated is often seen in patients suffering from COPD and makes the impairment of lung function more severe, as well as increasing the risk of the bronchial mucosa becoming colonised by bacteria.

Miguel Ángel Martínez-García, from La Fe University and Polytechnic Hospital in Valencia, Spain, who led the research, said the team found that if patients had moderate to severe COPD and bronchiectasis they were more likely to die from any cause, regardless of what their other risk factors were.

The risk of mortality depended on how serious the bronchiectasis was, according to the report which have been published online and will appear in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

The researchers studied 201 people suffering from moderate to severe COPD - classified according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Out of the patients participating in the study, 115 had bronchiectasis, which had been diagnosed by a CT scan of their chest, while the remaining 86 did not.

The progress of the patients was followed for an average of four years and during this period 51 of the participants died. More than 84% of these deaths were from the group with bronchiectasis, which saw 43 patients pass away.

But the authors warned that there were some limitations to the study. It had not been possible to accurately measure the exact size of the bacterial load in sputum samples and the analysis did not include some variables which have been shown to predict the risk of mortality among patients with COPD.



  • 1 Comment

Readers' comments (1)

  • I have been diagnosed COPD and chronic emphysema and also the antitrypsin deficiency for over 12 years. My principal symptom has been a heavy feeling in the chest. I cannot breathe well while lying flat on my back or on my right side.
    Two year ago i was about to go for lungs volume reduction just for me to live a better life at least,not until u was i ask to give a try on natural herbal formula which i emailed and purchased from them,the herbal remedies work perfectly on my system,i can only say that for me this treatment has worked well and has allowed me to live a normal life and I am extremely grateful to the herbal team.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.